Dementia with Lewy bodies is one of the most common causes of dementia. It is not as common as Alzheimer's disease; the general public's awareness of the disease is poor in comparison. Its effects on caregivers and patients alike are not well known to the general population. There are currently no FDA-approved medications specifically for the treatment of DLB. Many of the medications that are approved for Alzheimer's disease are widely used in the treatment of DLB with varying degrees of success. Treatment of DLB is life long and requires a dedicated team of physicians and caregivers to minimize the degree of morbidity and mortality experienced by the patients suffering from the disease as it progresses
\ua9 2018 The Author(s). Background: Dementia due to Alzheimer\u27s disease (AD) and dementia with L...
The Dementia with Lewy Bodies (DLB) Consortium has refined its recommendations about the clinical an...
The Dementia with Lewy Bodies (DLB) Consortium has refined its recommendations about the clinical an...
While Alzheimer’s disease is the most common and widely known cause of dementia, it is not the only ...
Introduction: The aim of this review was to investigate whether there is a faster cognitive decline ...
Despite being the second most common form of neurodegenerative dementia, dementia with Lewy bodies (...
Dementia with Lewy bodies (DLB) is an age-associated neurodegenerative disorder producing progressiv...
Dementia with Lewy bodies (DLB) is an age-associated neurodegenerative disorder producing progressiv...
Dementia with Lewy bodies is the second most common form of neurodegenerative dementia, yet scarce e...
Dementia with Lewy bodies (DLB) is an age-associated neurodegenerative disorder producing progressiv...
The Dementia with Lewy Bodies (DLB) Consortium has refined its recommendations about the clinical an...
Dementia with Lewy bodies (DLB) is a common form of dementia that is being increasingly recognized. ...
This is the publisher's version, also available electronically from http://www.neurology.org/content...
This is the publisher's version, also available electronically from http://www.neurology.org/content...
The Dementia with Lewy Bodies (DLB) Consortium has refined its recommendations about the clinical an...
\ua9 2018 The Author(s). Background: Dementia due to Alzheimer\u27s disease (AD) and dementia with L...
The Dementia with Lewy Bodies (DLB) Consortium has refined its recommendations about the clinical an...
The Dementia with Lewy Bodies (DLB) Consortium has refined its recommendations about the clinical an...
While Alzheimer’s disease is the most common and widely known cause of dementia, it is not the only ...
Introduction: The aim of this review was to investigate whether there is a faster cognitive decline ...
Despite being the second most common form of neurodegenerative dementia, dementia with Lewy bodies (...
Dementia with Lewy bodies (DLB) is an age-associated neurodegenerative disorder producing progressiv...
Dementia with Lewy bodies (DLB) is an age-associated neurodegenerative disorder producing progressiv...
Dementia with Lewy bodies is the second most common form of neurodegenerative dementia, yet scarce e...
Dementia with Lewy bodies (DLB) is an age-associated neurodegenerative disorder producing progressiv...
The Dementia with Lewy Bodies (DLB) Consortium has refined its recommendations about the clinical an...
Dementia with Lewy bodies (DLB) is a common form of dementia that is being increasingly recognized. ...
This is the publisher's version, also available electronically from http://www.neurology.org/content...
This is the publisher's version, also available electronically from http://www.neurology.org/content...
The Dementia with Lewy Bodies (DLB) Consortium has refined its recommendations about the clinical an...
\ua9 2018 The Author(s). Background: Dementia due to Alzheimer\u27s disease (AD) and dementia with L...
The Dementia with Lewy Bodies (DLB) Consortium has refined its recommendations about the clinical an...
The Dementia with Lewy Bodies (DLB) Consortium has refined its recommendations about the clinical an...